Comparison of cancer chemotherapeutic agents in asynchronous and synchronous 9L cells
β Scribed by Sheri D. Henderson; Brace F. Kimler; Mary L. Barnes
- Publisher
- Springer US
- Year
- 1987
- Tongue
- English
- Weight
- 651 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0167-6997
No coin nor oath required. For personal study only.
β¦ Synopsis
The cytotoxic activity of various chemotherapy agents was investigated in asynchronous populations of cultured 9L rat brain tumor cells, and as a function of their position in the cell cycle. Representative drugs from the classes of DNA-active agents, alkylating agents, spindle poisons, and antimetabolites were tested. The ability to induce cell lethality in asynchronous populations as a function of drug concentration varied for 1 hr pulse exposures. In order of decreasing cytotoxic activity, DHAQ was the most effective, followed by VCR, VDS, VBL, ADR, BCNU, cis-DDP, BLM, DBD, RZ, and HU. The effect of chemotherapy agents on synchronous 9L cells obtained by mitotic selection also varied with respect to the individual agent and was cell cycle-dependent. Survival age-responses ranged from being minimal to demonstrating significant fluctuations as a function of cell cycle position. For all agents except ADR and HU, the sensitivity of G1 phase was greater than S phase. RZ exhibited essentially a flat age-response. Comparison of the cell cycle age-responses of chemotherapeutic agents to those exhibited by the cytotoxic modalities of radiation and hyperthermia demonstrate several unique differences.
π SIMILAR VOLUMES
Ferrokinetic studies were performed i n 14 male patients with cancer who were given one of 5 different chemotherapeutic agents (methotrexate, fluorouracil, actinomycin D, hydroxyurea, galactoflavin). These drugs, which are capable of suppressing erythropoiesis via different mechanisms, produced simi
## Abstract Tumor necrosis factorβrelated apoptosisβinducing ligand (TRAIL) is a promising cancer therapeutic agent because of its tumor selectivity. TRAIL is known to induce apoptosis in cancer cells but spare most normal cells. In the previous study [Yoo and Lee, 2007], we have reported that hype
## Abstract Bone marrow cell responses to injections of nitrogen mustard, oncovin, procarbazine, hydrocortisone, and a regimen of all four drugs (MOPH) were evaluated in CRF1 and C57B 1/6 mice by determining bone marrow cellularity and content of transplantable colony forming units (CFU) after trea